Saint Sean 4

What Happened

Saint Sean, President & CEO (and director) of Beta Bionics, sold 16,872 shares on 2026-06-02 in an open-market/private sale for total proceeds of $212,707. The filing reports a per-share price of $12.61; the weighted average sale price was $12.6071 (range $12.30–$12.93). The filing states the shares were sold to satisfy tax withholding obligations arising from the vesting of restricted stock units (RSUs).

Key Details

• Transaction date: 2026-06-02; Form 4 filed 2026-06-03 (timely filing).
• Shares sold: 16,872; reported proceeds: $212,707.
• Reported price: $12.61 per share; weighted average $12.6071; price range $12.30–$12.93. (F2: full breakdown by price available on request.)
• Footnote: Sale was to cover tax withholding for RSU vesting (F1).
• Shares owned after the transaction: not specified in the provided filing excerpt.

Context

• This was a sale to cover tax obligations from vested RSUs (a routine, non-investment-driven disposition). Such tax-withholding sales are common and do not necessarily signal the insider’s view on the company’s prospects. Purchases by insiders typically carry more weight for interpreting sentiment.
• If you want the exact number of shares sold at each price within the reported range, the filing notes that full per-price details can be provided upon request.